【结 构 式】 |
【分子编号】12680 【品名】bromomethyl acetate 【CA登记号】590-97-6 |
【 分 子 式 】C3H5BrO2 【 分 子 量 】152.9755 【元素组成】C 23.55% H 3.29% Br 52.23% O 20.92% |
合成路线1
该中间体在本合成路线中的序号:(VI)1) The reaction of 3-pyridylcarbonyl chloride (I) with (3S,4R)-2-[3-[1(R)-hyroxyethyl]-2-oxo-4-sulfanylazetidin-1-yl]-2-(triphenylphosphoranylidene)acetic acid allyl ester silver salt (II) in dichloromethane containing pyridine gives the substituted phosphorane (III), which is cyclized in refluxing benzene to afford (5R,6S)-6-[1(R)-hydroxyethyl]-2-(3-pyridyl)-2-penem-3-carboxylic acid allyl ester (IV). The deprotection of (IV) by means of triphenylphosphine, tetrakis(triphenylphosphine)palladium and acetic acid yields the free acid (V), which is finally esterified with bromomethyl acetate (VI) in DMF.
【1】 Mealy, M.; Castaner, J.; TMA-230. Drugs Fut 1996, 21, 5, 493. |
【2】 Bedeschi, A.; Visentin, G.; Perrone, E.; et al.; Synthesis and structure-activity relations in the class 2-(pyridyl)penems. J Antibiot 1990, 43, 3, 306-13. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10753 | Nicotinoyl chloride | C6H4ClNO | 详情 | 详情 | |
(II) | 12676 | (3S,4R)-2-[3-(1(R)-Hydroxyethyl)-2-oxo-4-sulfanylazetidin-1-yl]-2-(triphenylphosphanylidene)acetic acid allyl ester S-silver salt | C28H27AgNO4PS | 详情 | 详情 | |
(III) | 12677 | allyl 2-[(3S,4R)-3-[(1R)-1-hydroxyethyl]-2-oxo-4-[(3-pyridinylcarbonyl)sulfanyl]azetidinyl]-2-(triphenylphosphoranylidene)acetate | C34H31N2O5PS | 详情 | 详情 | |
(IV) | 12678 | allyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(3-pyridinyl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | C16H16N2O4S | 详情 | 详情 | |
(V) | 12679 | (5R,6S)-6-[(1R)-1-Hydroxyethyl]-7-oxo-3-(3-pyridinyl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | C13H12N2O4S | 详情 | 详情 | |
(VI) | 12680 | bromomethyl acetate | 590-97-6 | C3H5BrO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VI)2) The reaction of 3-pyridylcarbonyl chloride (I) with (3S,4R)-2-[3-[1(R)-(allyloxycarbonyloxy)ethyl]-2-oxo-4-sulfanylazetidin-1-yl]-2-(triphenylphosphoranylidene)acetic acid allyl ester silver salt (VII) in dichloromethane containing pyridine gives the substituted phosphorane (VIII), which is cyclized in refluxing toluene to afford (5R,6S)-6-[1(R)-(allyloxycarbonyloxy)ethyl]-2-(3-pyridyl)-2-penem-3-carboxylic acid allyl ester (IX). The deprotection of (IX) with tetrakis(triphenylphosphine)palladium, tributyltin hydride and NaHCO3 in THF gives the free acid (X) as the sodium salt, which is finally esterified with bromomethyl acetate.
【1】 Mealy, M.; Castaner, J.; TMA-230. Drugs Fut 1996, 21, 5, 493. |
【2】 Lang, M. (Novartis AG); 2-Pyridyl-penem cpds. EP 0246187; JP 1987263183; US 4826832 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10753 | Nicotinoyl chloride | C6H4ClNO | 详情 | 详情 | |
(VI) | 12680 | bromomethyl acetate | 590-97-6 | C3H5BrO2 | 详情 | 详情 |
(VII) | 12681 | (3S,4R)-2-[3-[1(R)-(Allyloxycarbonyloxy)ethyl]-2-oxo-4-sulfanylazetidin-1-yl]-2-(triphenylphosphanylidene)acetic acid allyl ester S-silver salt | C32H31AgNO6PS | 详情 | 详情 | |
(VIII) | 12682 | allyl 2-[(3S,4R)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-2-oxo-4-[(3-pyridinylcarbonyl)sulfanyl]azetidinyl]-2-(triphenylphosphoranylidene)acetate | C38H35N2O7PS | 详情 | 详情 | |
(IX) | 12683 | allyl (5R,6S)-6-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-7-oxo-3-(3-pyridinyl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | C20H20N2O6S | 详情 | 详情 | |
(X) | 12684 | sodium (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(3-pyridinyl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | C13H11N2NaO4S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(III)Exposure of pyrrolidine (I) to NO in acetonitrile/ether in the presence of NaOMe in MeOH provides sodium 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (II), which is converted into the desired product by reaction with bromomethyl acetate (III) in DMSO in the presence of Na2CO3 and silver acetate (HgOAc).
【1】 Saavedra, J.E.; et al.; Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem 1997, 40, 13, 1947. |
【2】 Booth, M.N.; Keefer, L.K.; Shami, P.J.; Wang, L.Y.; Saavedra, J.E.; Davies, K.M.; Citro, M.L.; Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: In vitro antileukemic activity. J Med Chem 2000, 43, 2, 261. |
合成路线4
该中间体在本合成路线中的序号:(II)The alkylation of the triazole derivative (I) (compound 293408) with bromomethyl acetate (II) in hot acetonitrile produced the triazolium bromide salt (III). This was then treated either with ion-exchange resin or with a saturated solution of NaCl to produce the desired chloride salt. The analogous alkylation of (I) with iodomethyl acetate (IV) produced the iodide salt (V), which was finally converted to the corresponding chloride by treatment with a saturated solution of NaCl.
【1】 Itoh, K.; Okonogi, K.; Kitazaki, T. (Takeda Chemical Industries, Ltd.); Azole cpds., their production and their use. EP 0973768; JP 1999228548; JP 2000198773; WO 9843970 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 45518 | 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1,2,3,4-tetraazol-1-yl)phenyl]-2-imidazolidinone | C22H21F2N9O2 | 详情 | 详情 | |
(II) | 12680 | bromomethyl acetate | 590-97-6 | C3H5BrO2 | 详情 | 详情 |
(III) | 45519 | 4-[(acetoxy)methyl]-1-((2R,3R)-2-(2,4-difluorophenyl)-2-hydroxy-3-[2-oxo-3-[4-(1H-1,2,3,4-tetraazol-1-yl)phenyl]-1-imidazolidinyl]butyl)-1H-1,2,4-triazol-4-ium bromide | C25H26BrF2N9O4 | 详情 | 详情 | |
(IV) | 45520 | iodomethyl acetate | C3H5IO2 | 详情 | 详情 | |
(V) | 45521 | 4-[(acetoxy)methyl]-1-((2R,3R)-2-(2,4-difluorophenyl)-2-hydroxy-3-[2-oxo-3-[4-(1H-1,2,3,4-tetraazol-1-yl)phenyl]-1-imidazolidinyl]butyl)-1H-1,2,4-triazol-4-ium iodide | C25H26F2IN9O4 | 详情 | 详情 |